Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Phase IV study of Ailixin (aildenafil citrate tablets) for erectile dysfunction
CTR20232144Phase 4Active
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aildenafil in erectile dysfunction (ED), sponsored by Tianjin Institute of Pharmaceutical Research. Started Feb 2023; status: active.
02
Drugs
aildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20232144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232144.